Defendant Name:
MiMedx Group, Inc.
Defendant Type:
Public Company
Document Reference:
2019-243
Document Details
Legal Case Name
SEC v. MiMedx Group, Inc., Parker H. Petit, William C. Taylor, Michael J. Senken
Document Name
SEC Charges Biotech Company and Executives With Accounting Fraud
Document Date
26-Nov-2019
Document Format
Civil Proceeding
Case Number
19-cv-10927
Federal District Court
New York, Southern District of New York
Allegation Type
Issuer Reporting and Disclosure
Document Summary
The SEC stated that: "[It] charged Georgia-based biotech company MiMedx Group Inc. and three former top executives with defrauding investors by misstating the company’s revenue and attempting to cover up their misconduct. MiMedx has agreed to a settlement to resolve
the claims."
Disgorgement & Penalty Information
Resolutions
None Specified
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Monetary Penalties:
Total Penalty
Individual:
$1,500,000.00
Shared:
Other Defendants in Action: